CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
83 hedge funds and large institutions have $200M invested in CTI BioPharma Corp. (DE) Common Stock in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 9 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
83
Holders Change
+16
Holders Change %
+23.88%
% of All Funds
1.9%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
31
Increased
23
Reduced
9
Closed
15
Calls
$512K
Puts
$217K
Net Calls
+$295K
Net Calls Change
-$96K
Top Buyers
| 1 |
BlackRock
New York
|
+$11.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$3.99M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$2.36M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.18M |
Top Sellers
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$5.44M |
| 2 |
Goldman Sachs
New York
|
-$1.69M |
| 3 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$806K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$767K |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$747K |
